The role of the FcGRIIIa polymorphism in modifying the association between treatment and outcome in patients with rheumatoid arthritis treated with rituximab versus TNF-α antagonist therapies

Khaled Sarsour, Jeffrey Greenberg, Joseph A. Johnston, David R. Nelson, Lee A. O'Brien, Carole Oddoux, Harry Ostrer, Alex Pearlman, George Reed

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'The role of the FcGRIIIa polymorphism in modifying the association between treatment and outcome in patients with rheumatoid arthritis treated with rituximab versus TNF-α antagonist therapies'. Together they form a unique fingerprint.

Medicine & Life Sciences